ADDEX THERAPEUTICS LTD (ADXN)

US00654J2069 - ADR

8.42  -7.68 (-47.7%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
2.48M1.44M3.15M3.88M2.83M
Operating Expenses
16.84M21.97M18.66M16.12M17.44M
Research and Development
13.43M14.64M12.82M10.36M12.45M
Selling, General, and Administrative Expenses
7.15M7.29M5.81M5.74M4.98M
Operating Income
-14.36M-20.52M-15.51M-12.24M-14.60M
Interest Income/Expense
-194.32K-284.01K308.01K-615.32K-176.45K
Other Income/Expense
N/AN/A-220.00KN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-15.46M-20.80M-15.20M-12.86M-14.78M
Income Tax
0.000.000.00N/A0.00
Net Income
-15.46M-20.80M-15.20M-12.86M-14.78M
EBITDA
-14.06M-20.20M-15.16M-11.86M-14.27M
 
Per Share Data
EPS Diluted Total Ops
-18.82-33.58-32.49-35.15-40.79
Non GAAP EPS
N/A-9.54N/AN/AN/A
 
Statistics
Profit Margin
-623.88%-1439.78%-481.97%-331.48%-521.61%
Operating Profit Margin
-579.71%-1420.12%-491.73%-315.62%-515.38%

All data in CHF

Charts